 Aridis Pharmaceuticals Inc NASDAQ: ARDS has announced that its COVID-19 mAb cocktail AR-712 binds and neutralizes the Delta variant of COVID-19 at a highly effective level 20ngmL. Binding analyses project that AR-712 will be effective against all variants on the U.S. CDCs variants of interest and concern lists. 